Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Canine cancer fought using immune system cycles
golden retriever
The Biotempus team realised administering treatment at the wrong time could reduce its efficacy. (stock photo)
Medical trial in Ohio shows promise
 
A clinical immunotherapy trial in Ohio is reportedly giving some dogs with advanced cancer a new lease of life by using the immune system to their advantage.

Dr Carol Osborne, founder and director of Chagrin Falls Veterinary Center, is working with a research team at Biotempus Limited, Australia, after they made a remarkable discovery about the immune system.

Whilst researching AIDS in mice, it became apparent that some responded better to the same treatment at different times post-inoculation. The Biotempus team realised the immune system runs on a cycle (in both dogs and humans). Therefore, administering treatment at the wrong time could reduce its efficacy.

Dr Osborne's 'Synchronization of Immunotherapy' study began in April and is due to run until December. Daily blood tests are taken from dogs in the trial for a few weeks to find out when their immune system is strongest. When it reaches its peak, the patient receives chemotherapy drugs, making the medication more effective at triggering the immune system to fight cancer.

Chagrin Falls Veterinary Center highlights a number of success stories, including 11-year-old golden retriever Sophie who had a large tumour on her right shoulder and is said to be in remission after undergoing several weeks of the experimental treatment.

Likewise, 12-year-old Tibetan terrier Farley is said to be in remission after taking part in the trial for late stage liver cancer.

However, Dr Osborne says the treatment isn't working a miracle for all patients but it is not known at this stage why it works for some dogs, while others with the same types of cancer do not respond at all.

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
NSA webinar explores sheep tailing and castration

The National Sheep Association (NSA) is to host a free webinar on the castration and tail docking of lambs.

The webinar, 'Understanding the tailing and castration consultation: A guide for sheep farmers', will be hosted online on Monday, 2 March 2026 at 7.30pm.

It comes during a government consultation into the methods used for these procedures. Farmers are encouraged to engage before the consultation period closes on Monday, 9 March 2026.

The webinar offers clear and actionable guidance to support farmers to contribute meaningfully to the consultation and prepare for potential changes.

On the panel will be former SVS president Kate Hovers, farmer and vet Ann Van Eetvelt and SRUC professor in Animal Health and Veterinary Sciences Cathy Dwyer. Each panel member will utilise their own specialism and expertise to evaluate risks and outcomes to sheep farming.

Find out more about the webinar on the NSA website.